4.8 Article

Total Synthesis of (+/-)-Phomoidride D

期刊

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 57, 期 7, 页码 1991-1994

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201712369

关键词

bicyclic compounds; cycloaddition; natural products; oxidation; total synthesis

资金

  1. Bristol-Myers Squibb
  2. Eli Lilly
  3. Glaxo-Wellcome
  4. Astellas
  5. AstraZeneca
  6. Amgen
  7. Camille and Henry Dreyfus Foundation
  8. Baylor University
  9. Welch Foundation [AA-006]
  10. Cancer Prevention and Research Institute of Texas (CPRIT) [R1309]

向作者/读者索取更多资源

Described herein is a synthetic strategy for the total synthesis of (+/-)-phomoidrideD. This highly efficient and stereoselective approach provides rapid assembly of the carbocyclic core by way of a tandem phenolic oxidation/intramolecular Diels-Alder cycloaddition. A subsequent SmI2-mediated cyclization cascade delivers an isotwistane intermediate poised for a Wharton fragmentation that unveils the requisite bicyclo[4.3.1]decene skeleton and sets the stage for synthesis completion.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据